
Image by sharkolot on Pixabay · Pixabay License
Recent publications · Crossref
5 total works indexed
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
· 2010 · cited 1,744x
- Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
· 2008 · cited 1,306x
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
· 2021 · cited 1,138x
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
· 2023 · cited 653x
- <i>PIK3CA</i>
Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
· 2009 · cited 613x
via Crossref · CC0